Pentax 2012 Annual Report Download - page 16

Download and view the complete annual report

Please find page 16 of the 2012 Pentax annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

The number of cases of cataracts attributed to aging has been growing rapidly
due to the aging of the global population. Cataracts are a disorder of the eye, or
clouding that develops in the crystalline lens of the eye due to aging. They not
only cause vision loss, but potentially lead to blindness if untreated. An
intraocular lens (IOL) is an artificial crystalline lens used in an eye from which a
clouding crystalline lens has been removed during cataract surgery. It is an
innovative medical device that enables people who once suffered from
cataracts to see normally again.
There are two types of IOLs. One is a hard lens. The other is a soft, foldable
intraocular lens that allows the optical portion to be bent, permitting insertion
through a small incision. In recent years, demand for soft IOLs has been
growing as they reduce the burden on patients during surgery.
HOYA manufactures and sells lens injection systems that facilitate surgery,
along with soft, foldable IOLs that can be inserted through extremely small
incisions (the world's smallest 1.8mm incisions). In 2007, the company released
the iSert™ pre-loaded IOL delivery system. This product boasts significantly
higher operability than conventional products, and is contributing to healthcare
as a solution that ensures safe, secure cataract surgery.
The mainstay product, the iMics1, is a revolutionary IOL featuring both a sharp
edge and smooth optical surface. HOYA developed this product by using
materials proven to be safe and effective and by designing the aspherical
surface in a unique way. The company provides ophthalmologists with the
product in a pre-loaded surgical insertion system, which also minimizes the
incision size.
In 2009, HOYA entered the United States, the world's largest cataract IOL lens
market. The company commenced full-scale operation in the country with the
iSert, the country's first pre-loaded IOL delivery system permitting a small
incision size.
In Japan, HOYA launched the IOL business in 1987, or 25 years ago. The
company's products are highly acclaimed in hospitals and clinics for their
superior operability, as well as the high-quality lenses.
In 2011, HOYA transferred the headquarters of this business from the United
States to Singapore. The company has since been working on expanding the
business in the global market.
Pre-loaded IOL delivery system “iSert™”
IOL plant in Singapore
Intraocular Lenses for Cataract Treatment
Co
py
ri
g
ht 2012 © HOY
A
CORPORATION